Download PDF
Horm Metab Res 2003; 35(4): 259-264
DOI: 10.1055/s-2003-39483
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Effect of Parathyroidectomy on Bone Mineral Density in Hemodialysis Patients with Secondary Hyperparathyroidism: Possible Usefulness of Preoperative Determination of Parathyroid Hormone Level for Prediction of Bone Regain

S.  Yano 1, 2 , T.  Sugimoto 1 , T.  Tsukamoto 1 , T.  Yamaguchi 1 , T.  Hattori 3 , K.-I.  Sekita 3 , H.  Kaji 1, 3 , S.  Hattori 3 , A.  Kobayashi 4 , K.  Chihara 1
  • 1 Division of Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan
  • 2 Endocrine-Hypertension Division, Brigham and Women's Hospital, Boston, Massachusetts, USA
  • 3 Hattori Hospital, Miki, Japan
  • 4 Kobayashi Clinic, Kobe, Japan
Further Information

Publication History

Received 12 February 2002

Accepted after Revision 3 September 2002

Publication Date:
02 June 2003 (online)

Also available at
    Permissions and Reprints

Abstract

Purpose: To examine longitudinal changes of bone mineral density (BMD) after parathyroidectomy (PTx) in patients undergoing maintenance hemodialysis (HD) with severe secondary hyperparathyroidism (HPT) to determine which factor contributes most to bone changes. Methods: Fifteen Japanese HD patients who had been refractory to medical therapy were subject to PTx with autotransplantation. We measured BMD by dual energy X-ray absorptiometry (DXA) at the lumbar spine (L2 - 4 BMD) and the distal 1/3 region of the radius (1/3R BMD) at 1, 3, 6, 12, 24, and 36 months after PTx. Results: Baseline Z-score of BMD was markedly low at 1/3R (- 3.07) and slightly low at L2 - 4 (-0.59) in this group. A significant increase in L2 - 4 BMD was observed as early as one month after PTx, which was sustained afterwards. Annual percent changes in L2 - 4 and 1/3R BMD were + 15.6 % and + 6.4 %, respectively. The annual percent changes in BMD at both sites were positively associated with preoperative intact PTH levels (L2 - 4; r = 0.642, p = 0.010, 1/3R; r = 0.884, p < 0.001) and total alkaline phosphatase (ALP) levels (L2 - 4; r = 0.663, p = 0.007, 1/3R; r = 0.858, p < 0.001). Stepwise multiple regression analysis revealed that serum levels of intact PTH and ALP were the best predictors of both percentage and net changes in radial BMD with high determination coefficients (r2 > 0.8). Conclusion: Successful PTx following appropriate supplementation with vitamin D and calcium provides a marked increase in lumbar BMD and a modest increase in radial BMD in HD patients with secondary HPT. Preoperative levels of PTH and ALP are useful for predicting postoperative changes in bone mass.

Key words

Bone mineral density - Parathyroid hormone - Parathyroidectomy - Hyperparathyroidism - Dialysis

References

  • 1 Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.  Kidney Int. 1999;  56 1084-1093
    CrossrefPubMedGoogle Scholar
  • 2 Bianchi M L, Colantonio G, Montesano A, Trrevisan C, Ortolani S, Rossi R, Buccianti G. Bone status in different degrees of chronic renal failure.  Bone. 1992;  13 225-228
    CrossrefPubMedGoogle Scholar
  • 3 Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, Seto H, Sasayama S. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis.  Clin Nephrol. 1992;  38 149-153
    PubMedGoogle Scholar
  • 4 Foldes A J, Arnon E, Popovtzer M M. Reduced speed of sound in tibial bone of haemodialysed patients: association with serum PTH level.  Nephrol Dial Transplant. 1996;  11 1318-1321
    PubMedGoogle Scholar
  • 5 Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures.  Bone. 1996;  19 549-555
    CrossrefPubMedGoogle Scholar
  • 6 Taal M W, Masud T, Green D, Cassidy M. Risk factors for reduced bone density in haemodialysis patients.  Nephrol Dial Transplant. 1999;  14 1922-1928
    CrossrefPubMedGoogle Scholar
  • 7 Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis.  J Nephrol. 2000;  13 437-443
    PubMedGoogle Scholar
  • 8 Lindergard B, Johnell O, Nilsson B E, Wiklund P E. Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment.  Nephron. 1985;  39 122-129
    PubMedGoogle Scholar
  • 9 Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer M H. Monitoring of bone mineral content in patients on regular hemodialysis.  Nephron. 1989;  52 158-161
    PubMedGoogle Scholar
  • 10 Hutchinson A J, Whitehouse R W, Boulton H F. et al . Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.  Kidney Int. 1993;  44 1071-1077
    PubMedGoogle Scholar
  • 11 Lechleitner P, Krimbacher E, Genser N. et al . Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry.  Bone. 1994;  15 387-391
    CrossrefPubMedGoogle Scholar
  • 12 Schober H C, Han Z H, Foldes A J, Shih M S, Rao D S, Balena R, Parfitt A M. Mineralized bone loss at different sites in dialysis patients: Implications for prevention.  J Am Soc Nephrol. 1998;  9 1225-1233
    PubMedGoogle Scholar
  • 13 Chan T M, Pun K K, Cheng I KP. Total and regional bone densities in dialysis patients.  Nephrol Dial Transplant. 1992;  7 835-839
    PubMedGoogle Scholar
  • 14 Gabay C, Ruedin P, Slosman D, Bonjour J P, Leski M, Lizzoli R. Bone mineral density in patients with end-stage renal failure.  Am J Nephrol. 1993;  13 115-123
    PubMedGoogle Scholar
  • 15 Stein M S, Packham D K, Ebeling P R, Wark J D, Becker G J. Prevalence and risk factors for osteopenia in dialysis patients.  Am J Kidney Dis. 1996;  28 515-522
    PubMedGoogle Scholar
  • 16 Fontaine M A, Albert A, Dubois B, Saint-Remy A, Rorive G. Fracture and bone mineral density in hemodialysis patients.  Clin Nephro. 2000;  54 218-226
    PubMedGoogle Scholar
  • 17 Perfitt A M. 1986 Accelerated cortical bone loss: Primary and secondary hyperparathyroidism. In: Current Concepts of Bone Fragility,. edited by Uhthoff H New York; Springer-Verlag pp 279-285
    Google Scholar
  • 18 Parisien M, Mellish R W, Silverberg S J, Shane E, Lindsay R, Bilezikian J P, Dempster D W. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis.  J Bone Miner Res. 1992;  7 913-919
    PubMedGoogle Scholar
  • 19 Dempster D W, Parisien M, Silverberg S J, Liang X G, Schnitzer M, Shen V, Shane E, Kimmel D B, Recker R, Lindsay R, Bilezikian J P. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.  J Clin Endocrinol Metab. 1999;  84 1562-1566
    CrossrefPubMedGoogle Scholar
  • 20 Abugassa S, Nordenstrom J, Eriksson S, Mollerstrom G, Alveryd A. Skeletal remineralization after surgery for primary and secondary hyperparathyroidism.  Surgery. 1990;  107 128-133
    PubMedGoogle Scholar
  • 21 Garton M, Martin J, Stewart A, Matheson A, Robin S, Loveridge N, Reid D. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism.  Clin Endocrinol. 1995;  42 493-500
    CrossrefPubMedGoogle Scholar
  • 22 Silverberg S J, Gartenberg F, Jacobs T P, Shane E, Siris E, Staron R B, McMahon D J, Bilezikian J P. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.  Comment in: J Clin Endocrinol Metab. 1995;  80 729-734
    CrossrefPubMedGoogle Scholar
  • 23 Abdelhadi M, Nordenström J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.  J Clin Endocrinol Metab. 1998;  83 3845-3851
    CrossrefPubMedGoogle Scholar
  • 24 Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study.  Bone. 1999;  25 589-595
    CrossrefPubMedGoogle Scholar
  • 25 Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.  J Clin Endocrinol Metab. 2000;  85 1901-1907
    CrossrefPubMedGoogle Scholar
  • 26 Lindergard B, Gullstrand P, Rydmarker S, Tibblin S. Clinical evaluation of bone-densitometry in patients with final renal insufficiency operated for hyperparathyroidism.  Scand J Urol Nephrol. 1977;  11 59-67
    PubMedGoogle Scholar
  • 27 Kaye M, Rosenthall L, Hill R O, Tabah R J. Longterm outcome following total parathyroidectomy in patients with end-stage renal disease.  Clin Nephrol. 1993;  39 192-197
    PubMedGoogle Scholar
  • 28 Copley J B, Hui S L, Leapman S, Slemenda C W, Johnston C C Jr.. Longitudinal study of bone mass in end-stage renal disease patients: Effects of parathyroidectomy for renal osteodystrophy.  J Bone Miner Res. 1993;  8 415-422
    PubMedGoogle Scholar
  • 29 Chou F F, Lee C H, Lee C T. Muscle force and bone minerl density after parathyroidectomy and subcutaneous autotransplantation for secondary hyperparathyroidism.  World J Surg. 1999;  23 452-457
    PubMedGoogle Scholar
  • 30 Frolich M, Walma S T, Paulson C, Papapoulos S E. Immunoradiometric assay for intact human parathyroid hormone: Characteristics, clinical application and comparison with a radio-immunoassay.  Ann Clin Biochem. 1990;  27 69-72
    PubMedGoogle Scholar
  • 31 Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids.  Ann Rheum Dis. 1986;  45 852-857
    PubMedGoogle Scholar
  • 32 Uzawa T, Hori , Ejiri S, Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1 - 34) on rat bone.  Bone. 1995;  16 477-484
    PubMedGoogle Scholar
  • 33 Ishii H, Wada M, Furuya Y, Nagano N, Nemeth E F, Fox J. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.  Bone. 2000;  26 175-182
    CrossrefPubMedGoogle Scholar
  • 34 Mazzaferro S, Chicca S, Pasquali M, Zaraca F, Ballanti P, Taggi F, Coen G, Cinotti G A, Carboni M. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.  Nephrol Dial Transplant. 2000;  15 877-882
    PubMedGoogle Scholar
  • 35 Heaf J G, Nielsen L P, Mogensen N B. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.  Nephron. 1983;  35 103-110
    PubMedGoogle Scholar
  • 36 Silverberg S J, Locker F G, Bilezikian J P. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.  J Clin Endocrinol Metab. 1996;  81 4007-4012
    CrossrefPubMedGoogle Scholar
  • 37 Vestergaard P, Mollerup C L, Frokjaer V G, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.  BMJ. 2000;  321 598-602
    CrossrefPubMedGoogle Scholar
  • 38 Piraino B, Chen T, Cooperstein L, Segre G, Puschett J. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.  Clin Nephrol. 1988;  30 57-62
    PubMedGoogle Scholar
  • 39 Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy.  Am J Kidney Dis. 1999;  33 287-293
    PubMedGoogle Scholar
  • 40 Ross P D, Davis J W, Epstein R S, Wasnich R D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women.  Ann Intern Med. 1991;  114 919-923
    PubMedGoogle Scholar
  • 41 Melton L J, Atkinson E J, O'Fallon W M, Wahner H W, Riggs B L. Longterm fracture prediction by bone mineral assessed at different skeletal sites.  J Bone Miner Res. 1993;  8 1227-1233
    PubMedGoogle Scholar
  • 42 Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.  Am J Kidney Dis. 2000;  36 1115-1121
    PubMedGoogle Scholar
  • 43 Stracke S, Jehle P M, Sturm D, Schoenberg M H, Widmaier U, Beger H G, Keller F. Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure.  Am J Kidney Dis. 1999;  33 304-311
    CrossrefPubMedGoogle Scholar

S. Yano, M.D. & Ph. D.

Endocrine-Hypertension Division · Brigham and Women's Hospital

221 Longwood Avenue · Boston · MA 02115 · USA ·

Phone: +1(617)2780764

Fax: +1(617)732-5764

Email: syano@rics.bwh.harvard.edu